Simplex Trading’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,500
| Closed | -$2K | – | 9476 |
|
|
2025
Q2 | $2K | Buy |
2,500
+1,200
| +92% | +$1.47K | ﹤0.01% | 8139 |
|
|
2025
Q1 | $1K | Buy |
1,300
+900
| +225% | +$1.67K | ﹤0.01% | 8222 |
|
|
2024
Q4 | $2K | Sell |
400
-100
| -20% | -$1.19K | ﹤0.01% | 8019 |
|
|
2024
Q3 | $8K | Buy |
+500
| New | +$5.48K | ﹤0.01% | 7330 |
|
|
2023
Q4 | – | Sell |
-2,000
| Closed | -$16K | – | 9271 |
|
|
2023
Q3 | $16K | Buy |
+2,000
| New | +$17K | ﹤0.01% | 6815 |
|
|
2023
Q2 | – | Sell |
-400
| Closed | -$5K | – | 9402 |
|
|
2023
Q1 | $5K | Hold |
400
| – | – | ﹤0.01% | 8046 |
|
|
2022
Q4 | $6K | Sell |
400
-2,100
| -84% | -$42K | ﹤0.01% | 7930 |
|
|
2022
Q3 | $56K | Hold |
2,500
| – | – | ﹤0.01% | 6281 |
|
|
2022
Q2 | $45K | Sell |
2,500
-78,600
| -97% | -$1.4M | ﹤0.01% | 6643 |
|
|
2022
Q1 | $2.17M | Buy |
81,100
+72,700
| +865% | +$1.35M | ﹤0.01% | 2030 |
|
|
2021
Q4 | $246K | Buy |
8,400
+5,300
| +171% | +$263K | ﹤0.01% | 4869 |
|
|
2021
Q3 | $277K | Hold |
3,100
| – | – | ﹤0.01% | 5051 |
|
|
2021
Q2 | $257K | Buy |
3,100
+3,099
| +309,900% | +$230K | ﹤0.01% | 5249 |
|
|
2021
Q1 | $7K | Sell |
1
-5
| -83% | -$455 | ﹤0.01% | 8073 |
|
|
2020
Q4 | $52K | Sell |
6
-1
| -14% | -$70 | ﹤0.01% | 6136 |
|
|
2020
Q3 | $51K | Buy |
+7
| New | +$414 | ﹤0.01% | 5586 |
|
Other funds holding IGMS
Simplex Trading's IGMS Position: Q1 2025 in Review
Simplex Trading sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 561 shares — an estimated $1.04K sold.
Simplex Trading first reported a position in IGMS in Q3 2020 and held it in 8 quarters. The position peaked at $722K in Q3 2022. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.
- Simplex Trading reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 561 IGM Biosciences shares in Q1 2025, an estimated $1.04K.
- Simplex Trading first reported a position in IGM Biosciences in Q3 2020 and held it in 8 quarters.
- Simplex Trading's IGM Biosciences position peaked at $722K in Q3 2022.
- 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.